Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 595

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 595
---
6,000,000Units at a price of $ 10.00per Unit. On February17, 2023, the underwriters exercised their over -allotmentoption to purchase an additional 900,000Units. Each Unit consists of oneshare of common stock, oneredeemable warrant entitling the holder thereof to purchase oneshare of Common Stock at a price of $ 11.50per share, subject to adjustment, and oneright which entitles the holder thereof to receive one -tenth(1/10) of a share of common stock (see Note 6). Each warrant will become exercisable 30days after the consummation of an initial business combination, and will expire five yearsafter the completion of an initial business combination, or earlier upon redemption or liquidation. Each right entitles the holder thereof to receive one -tenth(1/10) of a share of common stock upon the consummation of an initial business combination, as described in more detail below. Each tenrights entitle the holder thereof to receive one share of common stock at the closing of a business combination. NOTE 4 — RELATED PARTY TRANSACTIONS Founder Shares On July30, 2020, the Sponsor purchased 1,437,500shares of the Company’s Common Stock (the “Founder Shares”) for an aggregate purchase price of $ 25,000, or approximately $ 0.017per share. On April25, 2022, the Company executed a 1.2 -for-onestock split, resulting in an aggregate of 1,725,000Founder Shares held by the Company’s sponsor, of which up to 225,000Founder Shares were subject to forfeiture to the extent that the underwriters’ over -allotmentoption was not exercised in full or in part. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) three yearsafter the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last sale price of the Common Stock equals or exceeds $ 12.50per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 -daytrading period commencing at least 150 days after the initial Business F-40 BELLEVUE LIFE SCIENCES ACQUISITION COR